Consolidated Financial Statements for the Second Quarter Ended September 30, 2021 FY2022 (April 1, 2021 - March 31, 2022) [UNAUDITED]
  • 2021/11/09
サブ-ナビゲーション
  • information
  • News
  • Corporate Guide
    • Message from the president
    • Corporate Data
    • Corporate History
    • Corporate Executives
    • Group
    • Access
  • Business
    • Reagents/Instruments
    • CDMO
    • Gene Therapy
  • Investor Relations
    • IR Library
    • 現在位置:IR News
    • Contact IR
  • Sustainability
    • News＆Topics
    • Policy
    • Materiality （Important Issues）
    • Sustainability Topics
    • Sustainability Index
  • Contact Us
    • Contact IR

Consolidated Financial Statements for the Second Quarter Ended September 30, 2021 FY2022 (April 1, 2021 - March 31, 2022) [UNAUDITED]

  • 2021/11/09

Back to List

PAGETOP
PAGETOP
  • CLOSE
  • MENU

サイト内検索

  • footer-content
  • menu
  • JA
  • EN
  • contact
  • gnavi-box